To test the role of ID2 in restraining GBM cell differentiation, we deleted the ID2 gene using CRISPR/Cas9 technology in G144 cells expressing inducible 5S-A ASCL1 (Fig. S6C,D). The gene discussed is ASCL1; the disease is glioblastoma.